Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen

Peptides

Volumn 76, Issue , 2016, Pages 108-114

  Sangaralingham, S Jeson ^a   Wang, Bing H ^b   Huang, Li ^b   Kumfu, Sirinart ^b   Ichiki, Tomoko ^a   Krum, Henry ^b   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cardiorenal; Fibrosis; Gene expression; Natriuretic peptides; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; MMP9 PROTEIN, RAT; NATRIURETIC FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIORENAL FIBROSIS; CONTROLLED STUDY; FIBROSIS; GENE EXPRESSION; HEART MUSCLE FIBROSIS; KIDNEY FIBROSIS; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CARDIAC MUSCLE; FISCHER 344 RAT; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; COLLAGEN; ENDOMYOCARDIAL FIBROSIS; FIBROSIS; GENE EXPRESSION; KIDNEY; MALE; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; NATRIURETIC PEPTIDES; RATS, INBRED F344; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84955480730     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.01.004     Document Type: Article

References (57)

1. M. Volpe Natriuretic peptides and cardio-renal disease Int. J. Cardiol. 176 2014 630 639
2. R. Zakeri, J.C. Burnett Jr., and S.J. Sangaralingham Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling Clin. Chim. Acta 443 2015 108 113
3. T.G. von Lueder, S.J. Sangaralingham, B.H. Wang, A.R. Kompa, D. Atar, J.C. Burnett Jr., and et al. Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure Circ. Heart Fail. 6 2013 594 605
4. A. Biernacka, and N.G. Frangogiannis Aging and cardiac fibrosis Aging Dis. 2 2011 158 173
5. X.J. Zhou, D. Rakheja, X. Yu, R. Saxena, N.D. Vaziri, and F.G. Silva The aging kidney Kidney Int. 74 2008 710 720
6. F.T. Bosman, and I. Stamenkovic Functional structure and composition of the extracellular matrix J. Pathol. 200 2003 423 428
7. L. Cao, and D.G. Gardner Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts Hypertension 25 1995 227 234
8. P. Li, D. Wang, J. Lucas, S. Oparil, D. Xing, X. Cao, and et al. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts Circ. Res. 102 2008 185 192
9. T. Horio, T. Tokudome, T. Maki, F. Yoshihara, S. Suga, T. Nishikimi, and et al. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts Endocrinology 144 2003 2279 2284
10. A. Leask Getting to the heart of the matter: new insights into cardiac fibrosis Circ. Res. 116 2015 1269 1276
11. Y. Sun, J. Zhang, J.Q. Zhang, and F.J. Ramires Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats Hypertension 35 2000 1078 1084
12. R.J. McAnulty Fibroblasts and myofibroblasts: their source, function and role in disease Int. J. Biochem. Cell Biol. 39 2007 666 671
13. D. Fan, A. Takawale, J. Lee, and Z. Kassiri Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease Fibrogenesis Tissue Repair 5 2012 15
14. F.G. Spinale Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ. Res. 90 2002 520 530
15. D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window Cardiovasc. Res. 69 2006 604 613
16. E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, C. Eng, L.T. Clark, and et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction Am. Heart J. 151 2006 1101.e1 1101.e8
17. A.A. Eddy, H. Kim, J. Lopez-Guisa, T. Oda, and P.D. Soloway Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective Kidney Int. 58 2000 618 628
18. A.T. Yan, R.T. Yan, F.G. Spinale, R. Afzal, H.R. Gunasinghe, M. Arnold, and et al. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure J. Card. Fail. 12 2006 514 519
19. K.S. Moshal, N. Tyagi, V. Moss, B. Henderson, M. Steed, A. Ovechkin, and et al. Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure J. Cell. Mol. Med. 9 2005 704 713
20. A. Ducharme, S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L.E. Rohde, and et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction J. Clin. Invest. 106 2000 55 62
21. E.E. Creemers, J.N. Davis, A.M. Parkhurst, P. Leenders, K.B. Dowdy, E. Hapke, and et al. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice Am. J. Physiol. Heart Circ. Physiol. 284 2003 H364 H371
22. S. Heymans, A. Luttun, D. Nuyens, G. Theilmeier, E. Creemers, L. Moons, and et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nat. Med. 5 1999 1135 1142
23. R.L. Sprott, and I. Ramirez Current inbred and hybrid rat and mouse models for gereontological research ILAR J. 38 1997 104 109
24. C.K. Abrass, M.J. Adcox, and G.J. Raugi Aging-associated changes in renal extracellular matrix Am. J. Pathol. 146 1995 742 752
25. P. Anversa, T. Palackal, E.H. Sonnenblick, G. Olivetti, L.G. Meggs, and J.M. Capasso Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart Circ. Res. 67 1990 871 885
26. P. Pacher, J.G. Mabley, L. Liaudet, O.V. Evgenov, A. Marton, G. Hasko, and et al. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure Am. J. Physiol. Heart Circ. Physiol. 287 2004 H2132 H2137
27. M.S. Razzaque, I. Shimokawa, A. Nazneen, Y. Higami, and T. Taguchi Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47 Cell Tissue Res. 293 1998 471 478
28. S.J. Sangaralingham, D.M. Heublein, J.P. Grande, A. Cataliotti, A.D. Rule, P.M. McKie, and et al. Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging Am. J. Physiol. Renal Physiol. 301 2011 F943 F952
29. S.J. Sangaralingham, B.K. Huntley, F.L. Martin, P.M. McKie, D. Bellavia, T. Ichiki, and et al. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide Hypertension 57 2011 201 207
30. S.J. Sangaralingham, E.L. Ritman, P.M. McKie, T. Ichiki, A. Lerman, C.G. Scott, and et al. Cardiac micro-computed tomography imaging of the aging coronary vasculature Circ. Cardiovasc. Imaging 5 2012 518 524
31. T. Ohtani, S.F. Mohammed, K. Yamamoto, S.M. Dunlay, S.A. Weston, Y. Sakata, and et al. Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction Eur. Heart J. 33 2012 1742 1749
32. T.G. von Lueder, B.H. Wang, A.R. Kompa, L. Huang, R. Webb, P. Jordaan, and et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy Circ. Heart Fail. 8 2015 71 78
33. J.C. Burnett Jr., P.C. Kao, D.C. Hu, D.W. Heser, D. Heublein, J.P. Granger, and et al. Atrial natriuretic peptide elevation in congestive heart failure in the human Science 231 1986 1145 1147
34. O. Lisy, M.M. Redfield, S. Jovanovic, M. Jougasaki, A. Jovanovic, H. Leskinen, and et al. Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function in vivo Circulation 102 2000 338 343
35. J. Sancho, and E. Haber A direct microassay for aldosterone in plasma extracts J. Clin. Endocrinol. Metab. 47 1978 391 396
36. S. Lekawanvijit, A.R. Kompa, Y. Zhang, B.H. Wang, D.J. Kelly, and H. Krum Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome Am. J. Physiol. Heart Circ. Physiol. 302 2012 H1884 H1893
37. M. Eghbali, M. Eghbali, T.F. Robinson, S. Seifter, and O.O. Blumenfeld Collagen accumulation in heart ventricles as a function of growth and aging Cardiovasc. Res. 23 1989 723 729
38. N. Gagliano, B. Arosio, D. Santambrogio, M.R. Balestrieri, G. Padoani, J. Tagliabue, and et al. Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex J. Gerontol. A Biol. Sci. Med. Sci. 55 2000 B365 B372
39. M. Volpe, S. Rubattu, and J. Burnett Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives Eur. Heart J. 35 2014 419 425
40. G. Zhou, J.C. Kandala, S.C. Tyagi, L.C. Katwa, and K.T. Weber Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts Mol. Cell. Biochem. 154 1996 171 178
41. S.E. Campbell, and L.C. Katwa Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts J. Mol. Cell. Cardiol. 29 1997 1947 1958
42. A.A. Lee, W.H. Dillmann, A.D. McCulloch, and F.J. Villarreal Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts J. Mol. Cell. Cardiol. 27 1995 2347 2357
43. S.E. Campbell, J.S. Janicki, and K.T. Weber Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone J. Mol. Cell. Cardiol. 27 1995 1545 1560
44. E.P. Bottinger, and M. Bitzer TGF-beta signaling in renal disease J. Am. Soc. Nephrol. 13 2002 2600 2610
45. M. Bujak, and N.G. Frangogiannis The role of TGF-beta signaling in myocardial infarction and cardiac remodeling Cardiovasc. Res. 74 2007 184 195
46. M. Fragiadaki, T. Ikeda, A. Witherden, R.M. Mason, D. Abraham, and G. Bou-Gharios High doses of TGF-beta potently suppress type I collagen via the transcription factor CUX1 Mol. Biol. Cell 22 2011 1836 1844
47. T. Kudo, and A. Baird Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor Nature 312 1984 756 757
48. H. Nakagawa, H. Oberwinkler, V.O. Nikolaev, B. Gassner, S. Umbenhauer, H. Wagner, and et al. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation Circ. Heart Fail. 7 2014 814 821
49. J.C. Burnett Jr., J.P. Granger, and T.J. Opgenorth Effects of synthetic atrial natriuretic factor on renal function and renin release Am. J. Physiol. 247 1984 F863 F866
50. A. Kilic, A. Bubikat, B. Gassner, H.A. Baba, and M. Kuhn Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling Endocrinology 148 2007 4162 4169
51. T. Nishikimi, C. Inaba-Iemura, K. Ishimura, K. Tadokoro, S. Koshikawa, K. Ishikawa, and et al. Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice Regul. Pept. 154 2009 44 53
52. N. Ishigaki, N. Yamamoto, H. Jin, K. Uchida, S. Terai, and I. Sakaida Continuos intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat Biochem. Biophys. Res. Commun. 378 2009 354 359
53. J.A. Pollack, J.P. Skvorak, S.J. Nazian, C.S. Landon, and J.R. Dietz Alterations in atrial natriuretic peptide (ANP) secretion and renal effects in aging J. Gerontol. A Biol. Sci. Med. Sci. 52 1997 B196 B202
54. K.M. Davis, L.C. Fish, K.L. Minaker, and D. Elahi Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease J. Gerontol. A Biol. Sci. Med. Sci. 51 1996 M95 M101
55. S.Q. Wu, C.Y. Kwan, and F. Tang The effect of aging on ANP levels in the plasma, heart, and brain of rats J. Gerontol. A Biol. Sci. Med. Sci. 52 1997 B250 B254
56. D.E. Gomez, D.F. Alonso, H. Yoshiji, and U.P. Thorgeirsson Tissue inhibitors of metalloproteinases: structure, regulation and biological functions Eur. J. Cell Biol. 74 1997 111 122
57. D.D. Bonnema, C.S. Webb, W.R. Pennington, R.E. Stroud, A.E. Leonardi, L.L. Clark, and et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) J. Card. Fail. 13 2007 530 540